Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Shares Outstanding (Diluted Average) (2021 - 2025)

BioAtla (BCAB) has disclosed Shares Outstanding (Diluted Average) for 5 consecutive years, with $58.8 million as the latest value for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 21.11% year-over-year to $58.8 million; the TTM value through Dec 2025 reached $58.8 million, up 21.11%, while the annual FY2025 figure was $58.8 million, 21.11% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $58.8 million in Q4 2025 for BioAtla, up from $58.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $58.8 million in Q4 2025 and bottomed at $33.7 million in Q2 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $45.8 million, with a median of $47.7 million recorded in 2023.
  • Year-over-year, Shares Outstanding (Diluted Average) grew 27.48% in 2023 and then grew 1.06% in 2024.
  • BioAtla's Shares Outstanding (Diluted Average) stood at $34.6 million in 2021, then increased by 12.63% to $38.9 million in 2022, then increased by 22.74% to $47.8 million in 2023, then rose by 1.67% to $48.6 million in 2024, then rose by 21.11% to $58.8 million in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $58.8 million, $58.5 million, and $58.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.